rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2000-2-24
|
pubmed:abstractText |
Epidemiological data suggest that chronic hepatitis C virus (HCV) infection may contribute to the development of diabetes mellitus. Therapy of HCV infection with recombinant interferon-alpha (r-IFN-alpha) can also impair of glucose metabolism.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0014-2972
|
pubmed:author |
pubmed-author:BergerAA,
pubmed-author:BowesR KRK,
pubmed-author:CobelliCC,
pubmed-author:HerrmannGG,
pubmed-author:KonradTT,
pubmed-author:KustererKK,
pubmed-author:LormansAA,
pubmed-author:TeuberGG,
pubmed-author:ToffoloGG,
pubmed-author:UsadelK HKH,
pubmed-author:ViciniPP,
pubmed-author:ZeuzemSS
|
pubmed:issnType |
Print
|
pubmed:volume |
30
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
111-21
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:10651835-Blood Glucose,
pubmed-meshheading:10651835-Diabetes Mellitus,
pubmed-meshheading:10651835-Fasting,
pubmed-meshheading:10651835-Female,
pubmed-meshheading:10651835-Glucose Tolerance Test,
pubmed-meshheading:10651835-Hepatitis C, Chronic,
pubmed-meshheading:10651835-Homeostasis,
pubmed-meshheading:10651835-Humans,
pubmed-meshheading:10651835-Insulin,
pubmed-meshheading:10651835-Interferon-alpha,
pubmed-meshheading:10651835-Liver Cirrhosis,
pubmed-meshheading:10651835-Male,
pubmed-meshheading:10651835-Regression Analysis
|
pubmed:year |
2000
|
pubmed:articleTitle |
Evaluation of factors controlling glucose tolerance in patients with HCV infection before and after 4 months therapy with interferon-alpha.
|
pubmed:affiliation |
J.W. Goethe-University, Frankfurt, Germany.
|
pubmed:publicationType |
Journal Article
|